Glaucoma 360 New Horizons Forum
Glaucoma 360 New Horizons Forum
February 16, 2018
1 min watch

VIDEO: MicroPulse technology reduces IOP in wide range of glaucomatous eyes

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact

SAN FRANCISCO ― At the Glaucoma 360: New Horizons Forum, Shan Lin, MD, talks about a study he and colleagues at UCSF have initiated, using Iridex's MicroPulse laser technology in transscleral cyclophotocoagulation in patients with a range of mild to refractory glaucoma. The technology has so far successfully lowered IOP 20% or more in 68% of eyes treated, he said.